Citations(0)

Content

How to Cite This Article

Download Download [ PDF ]

Email Send to a friend

Page Views Page Views(2075)

Facebook ShareFacebook Share

Twitter ShareTwitter Share

Year : 2015 Month : March Volume : 4 Issue : 19 Page : 3247-3253

TO COMPARE THE EFFICACY OF INTRAMUSCULAR PHENYLEPHRINE AND EPHEDRINE IN LSCS TO AVOID POST SPINAL HYPOTENSION

Jaideep Singh1, Pallavi Singh2, Aditya Agarwal3, Pooja Ahuja4

1. Assistant Professor, Department of Anaesthesia, Gandhi Medical College, Bhopal, MP.
2. Assistant Professor, Department of Obstetrics & Gynaecology, Gandhi Medical College, Bhopal, MP.
3. Professor, Department of Anaesthesia, Gandhi Medical College, Bhopal, MP.
4. Junior Resident, Department of Anaesthesiology, Gandhi Medical College, Bhopal, MP.

CORRESPONDING AUTHOR

Dr. Jaideep Singh,
Email : singhdrjaideep@gmail.com

ABSTRACT

CORRESPONDING AUTHOR:
Dr. Jaideep Singh,
17 HIG, Uma VIhar,
Rajharsh Colony,
Kolar Road,
Bhopal, Mp.
E-mail: singhdrjaideep@gmail.com

ABSTRACT: INTRODUCTION: Hypotension during Spinal Anesthesia Subarachnoid block for LSCS is secondary to the sympathetic blockade and aorto-caval compression by the uterus and it can be deleterious to both fetus and mother. Ephedrine and phenylephrine improve venous return after sympathetic blockade during Subarachnoid block. AIMS AND OBJECTIVES: The objective of this study was to assess the role of Intramuscular phenylephrine and ephedrine and to compare the efficacy of Intra muscular Phenylephrine and ephedrine in LSCS to avoid post spinal hypotension. MATERIALS AND METHODS: Ninty patients undergoing subarachnoid block with 0.5% Bupivicaine heavy for LSCS in Left Lateral Position in L3 - L4  Interspinous space via 25 G Spinal Needle under full asepsis were randomly divided into 3 groups.  GROUP A: Received neither i.m. phenylephrine nor i.m. ephedrine. Only Co-loading with crystalloid. GROUP B: Received intramuscular ephedrine (25 mg) 10 minute prior to spinal anaesthesia & Co-loading with crystalloid. GROUP C: Received intramuscular phenylephrine (2 mg) 10 minute prior to spinal anaesthesia. & Co-loading with crystalloid. PATIENT SELECTION CRITERIA: INCLUSION CRITERIA: Full Term Pregnancy, ASA Grade - I and Grade – II. EXCLUSION CRITERION: Contraindications for spinal block, coagulopathies, eclamptic and preeclamptic patient. INVESTIGATION REQUIRED: Routine Investigation, CBC, PTT, APTT, INR, Urine Investigation. DISCUSSION: Phenylephrine and ephedrine are comparable vasopressors when used to treat hypotension during caesarian section after spinal anaesthesia. Significant difference in HR between groups can primarily attributed to the decline in HR observed with phenylephrine and increase in HR associated with Ephedrine. The incidence of tachycardia was significantly higher in Ephedrine group due to its B1-agonist property. Furthermore, the incidence of fetal tachycardia with Ephedrine was more significant in another study. This studies shows significant hypotension in Group –A in which no vasopressors were given as compared to Group –B (Ephedrine) and Group-C.(Phenylephrine). If we compare Group-B and Group-C, significant hypotension observed in Group-B as compared to Group C. Ephedrine increases B. P by increasing the release of Norepinephrine and has not been shown to decrease blood flow to uterus. However, many recent studies shows decrease in fetal umbilical PH while phenylephrine doesn’t. This again corroborates the conclusions drawn from extensive review article by Lee et al. that fetal umbilical pH was lower in parturients who received ephedrine than in those who received phenylephrine. Furthermore our results are in concurrence with a number of recent studies indicating nausea and vomiting more with Ephedrine usage. RESULT: Decline from the basal heart rate was observed in phenylephrine group but was not significant across all measured times except at T=4, T=6 and T=8 min. An increase in heart rate from basal levels was seen in ephedrine group across all times and this at each time was significant. No significant difference in SBP between the groups was recorded at all measured points except at T = 4 min and T= 6 min, where SBP of patients in group B was significantly lower than SBP of patients in group C (p < 0.05). Diastolic blood pressure was comparable between the ephedrine and phenylephrine groups for all measured times.  Overall, phenylephrine was associated with a significantly better maintained systolic blood pressure (p < 0.05) and mean  blood pressure (p < 0.05) as compared to ephedrine. CONCLUSION: Both ephedrine and phenylephrine can safely be employed to combat hypotension in patient undergoing caesarian section under spinal anaesthesia. My study reports Phenylephrine as better vasopressors compared to Ephedrine regarding prevention and control of maternal hypotension. The incidence of nausea, vomiting, maternal tachycardia are more with ephedrine usage than phenylephrine.

KEYWORDS: Intramuscular, Phenylephrine, Ephedrine, LSCS, Post Spinal Hypotension.

INTRODUCTION:

  • Spinal anaesthesia is now a days considered the standard anaesthetic technique for elective caesarian section [1] because of the introduction of small gauge, non-cutting spinal needles.
  • However, the chance of hypotension is a major limitation of this technique. The incidence of hypotension is more than 80% without any prophylactic measures. [2,3]
  • The hypotension with or without bradycardia has detrimental effects on both mother and foetus.[4,5]
  • Maternal symptoms include nausea, vomiting and a sense of “impending doom” from inadequate cerebral perfusion. Inadequate treatment of hypotension can ultimately end with the loss of consciousness and cardiovascular collapse.
  • The fetus is indirectly affected by the development of hypotension, because of its dependency on maternal uterine artery pressure for adequate uterine blood flow.
  • With a persistent reduction in uterine blood flow, fetal acidosis will occur. The incidence of hypotension can be lowered by several ways but till date, no single method completely prevents hypotension.[4,5]
  • Over the last few years, there is a trend to rely more on vasopressors than either crystalloid or colloid alone.[4,6,7]
  • Different vasopressors are commonly used at present with varying degree of success like ephedrine phenylephrine, epinephrine, mephentermine.[6]

 

METHODS AND MATERIAL:

INCLUSION CRITERIA:

  • older than 18 years.
  • A.S.A physical status I or II weighing more than 50 kg and less than 90 kg uncomplicated singleton pregnancy beyond 36 weeks scheduled to have elective caesarean section under spinal anaesthesia.

 

EXCLUSION CRITERIA:

  • pregnancy induced hypertension.
  • chronic hypertension.
  • cardiac disease.
  • renal disease.
  • foetal anamoly.
  • diabetes mellitus.
  • patients on chronic medication.

TYPE OF STUDY:

  • Prospective, Randomised, double blind study.
  • ECG, NIBP, urine output and SPO2 were monitored.
  • Baseline maternal hemodynamic variables were recorded.
  • Intravenous preloading was done with 15 ml/kg Ringer’s lactate solution.
  • Spinal anaesthesia was administered at L3-L4 interspinous space with Quinke’s spinal needle 25G in left lateral position under full asepsis.
  • A dose of 12.5 mg hyperbaric bupivacaine was given over 10-13 sec.
  • Patients were randomly allocated by block randomization method, where one patient had every chance to get allocated in any group by randomized method.
  • 90 Patients were divided into 3 groups, 30 each.

 

GROUP-A: received no vasopressor.

GROUP-B: received 15 mg of intramuscular ephedrine 10 min before spinal anesthesia.

GROUP-C: received 2mg of intramuscular phenylephrine 10 min before spinal anesthesia.

  • Patients were given either intramuscular phenylephrine or Ephedrine by anaesthesiologist who was blinded about the drug in the labeled syringe.
  • Patients were placed supine with 15 degree left-tilt immediately after the spinal injection.
  • If hypotension occurred, defined as fall of SBP < 90 mmHg or 20% less than the basal SBP, patients were given either intramuscular phenylephrine or Ephedrine by anaesthesiologist who was blinded about the drug in the labeled syringe.
  • Time of vasopressor administration, duration of surgery and time of neonate extraction were recorded after the start of surgery.
  • SBP, DBP and Heart rate were taken every 2 min after the spinal until cord clamping and thereafter every 5 min till surgery completed.
  • All incidences of bradycardia, tachycardia, nausea and vomiting noted. Neonatal well-being was taking care by attending neonatologist.
  • Patients were monitored postoperatively for 24 hr for adverse effects.

 

Statistical Analysis:

  • Summary statistics of age, weight for all the 3 groups were reported as mean +SD
  • Intra and intergroup analysis for HR, SBP, DBP, MAP were statistically evaluated using one way ANOVA and paired T-test, where p=0.05 was considered significant and p<0.001 highly significant.
  • Complications nausea, vomiting, tachycardia and bradycardia were evaluated with Fisher’s Exact test, where p< o.o5 was considered significant and p< 0.001 highly significant.

 

Results:

  • Decline from the basal heart rate was observed in phenylephrine group but was not significant across all measured times except at T=4, T=6 and T=8 min.
  • An increase in heart rate from base levels was seen in ephedrine group across all times and this at each time was significant.
  • No significant difference in SBP between the groups was recorded at all measured points except at T = 4 min and T= 6 min, where SBP of patients in group B was significantly lower than SBP of patients in group C (p < 0.05).
  • Diastolic blood pressure was comparable between the ephedrine and phenylephrine groups for all measured times.
  • Overall, phenylephrine was associated with a significantly better maintained systolic blood pressure (p < 0.05) and mean arterial pressure (p < 0.05) as compared to ephedrine.

 

Time(min)

Control group means(SD)

(beats/min)

Ephedrine group means(SD)

(beats/min)

Phenylephrinegroup means(SD)

(beats/min)

p value

Basal

87(16.92)

82.8(18.32)

87.85(13.62)

0.3989

0

83(14.05)

86.5(20.01)

81.45(13.35)

0.4633

2

85(8.04)

86.1(8.03)

85(14.48)

0.8985

4

83(7.58)

89.7(17.42)

77(10.72)

0.0009

6

89(11.41)

86.1(9.84)

80(7.45)

0.0019

8

95(12.08)

97.77 (12.88)

87.30 (14.23)

0.0077

10

86(9.08)

101.18 (12.93)

92.78 (13.78)

0.019

15

99(11.89)

101.86 (11.96)

92.68 (11.88)

0.0119

20

98.02(9.91)

101.09 (11.89)

94 (12.32)

0.015

25

102(8.33)

102.98 (11.99)

95.54 (11.09)

0.0155

30

102.43(11.23)

101.87 (12.93)

94.23 (11.09)

0.0134

45

103.11(10.87)

101.09 (12.29)

94.87 (11.09)

0.176

60

101.88(11.23)

98.75 (11.87)

95.34 (10.87)

0.088

TABLE 1: Mean heart rate values

 

Fig. 1: Systolic Blood Pressure


Fig. 2: Diastolic blood pressure

 

 

Control group

means (SD)

Ephedrine group

 means (SD)

Phenylephrine

group means (SD)

P value

Time of vasopressor

administration (min)

4.62

(5.1)

4.66

(4.9)

3.87

(3.76)

0.7581

Maximum HR after vasopressor administration (beats/min)

105.4

(12.44)

110.8

(10.54)

98.78

(8.76)

0.0002

Minimum HR after vasopressor administration(beats/min)

93.76

(12.45)

91.31

(11.97)

75.76

(10.87)

<0.0001

Maximum SBP after vasopressor administration (mmHg)

124.76

(7.99)

125.46

(8.45)

127.87

(8.32)

0.3147

Minimum SBP after vasopressor administration(mmHg)

98.72

(19.78)

99.87

(12.99)

105.01

(9.99)

0.2223

TABLE 2

 

Complications between groups A

Control group, n (%)

B

Ephedrine

group, n (%)

C

Phenylephrine

group, n (%)

Nausea

10(33.3)

6(20)

2(6.6)

Vomiting

10(33.3)

7(21)

2(6.6)

Decline in heart rate

2(6.6)

1(3.3)

12(40)

Tachycardia

4(13.3)

10(33.3)

0(0)

TABLE 3

 

 

Discussion: Phenylephrine and ephedrine are comparable vasopressors when used to treat hypotension during caesarian section after spinal anaesthesia.

Significant difference in HR between groups can primary attributed to the decline in HR observed with phenylephrine and increase in HR associated with Ephedrine.

The incidence of tachycardia was significantly higher in Ephedrine group due to its B1-agonist property.[8]

Furthermore, the incidence of fetal tachycardia with Ephedrine was more significant in another study. Though FHR was not measured in this study. (mention references).

This studies shows significant hypotension in Group –A in which no vasopressor given as compared to Group –B (Ephedrine) and Group-C. (Phenylephrine). If we compare Group-B and Group-C, significant hypotension observed in Group-B (Ephedrine) as compared to Group C.

Ephedrine increases B.P by increasing the release of Norepinephrine and has not been shown to decrease blood flow to uterus. However, many recent studies shows decrease in fetal umbilical PH while phenylephrine doesn’t.[9,10] This again corroborates the conclusions drawn from extensive review article by Lee et al.  that fetal umbilical pH was lower in parturients who received ephedrine than in those who received phenylephrine.

Furthermore our results are in concurrence with a number of recent studies indicating nausea and vomiting more with Ephedrine usage.[11,12]

 

Conclusion: Both ephedrine and phenylephrine can safely be employed to combat hypotension in patient undergoing caesarian section under spinal anesthesia.

My study reports Phenylephrine as better vasopressoras compared to Ephedrine regarding prevention and control of maternal hypotension.

The incidence of nausea, vomiting, maternal tachycardia are more with ephedrine usage than phenylephrine.

 

REFERENCES:

1.    Sreevidya S, Sathiyasekaran BW. High caesarean rates in Madras (India): a population-based cross sectional study. BJOG 2003; 110: 106-11.
2.    Sufang G, Padmadas S S, Fengmin Z, Brown J, Stones RW. Delivery settings and caesarean section rates in China. Bull World Health Organ 2007; 85: 755-62.
3.    Smith GC, Cordeaux Y, White IR, et al. The effect of delaying childbirth on primary Cesarean section rates. PLoSMed 2008; 5: 1123-32.
4.    Festin MR, Laopaiboon M, Pattanittum P, Ewens M, Henderson-Smart D, Crowther C. Caesarean section in four South East Asian countries: reasons for, rates, associated care practices and health outcomes. BMC Pregnancy Childbirth 2009; 9: 17.
5.    StamerUM, Wiese R, StuberF, Wulf H, Meuser T. Change in anaesthetic practice for Caesarean section in Germany. Acta Anaesthesiol Scand2005; 49: 170-6.
6.    Enohumah KO, Imarengiaye CO. Factors associated with anaesthesia-related maternal mortality in a tertiary hospital in Nigeria. Acta Anaesthesiol Scand 2006; 50: 206-10.
7.    Popham P, Buettner A, Mendola M. Anaesthesia for emergency caesarean section, 2000-2004, at the Royal Women’s Hospital, Melbourne. Anaesth. Intensive Care 2007; 35: 74-9.
8.    McDonnell NJ. Difficult and failed intubation in obstetric anaesthesia; an observational study of airway management and complications associated with general anaesthesia. IntJ ObstetAnesth2008; 17: 292-7.
9.    Algert CS, Bowen JR, Giles WB, Knoblanche GE, Lain SJ, Roberts CL. Regional block versus general anaesthesia for caesarean section and neonatal outcomes: a population based study. BMC Medicine 2009; 7: 20.
10.    ChoiDH, Kim JA, Chung IS. Comparison of combined spinal epidural anesthesia and epidural anesthesia for Cesarean section. Acta AnaesthesiolScand2000; 44: 214-9.
11.    Cleary-Goldman J, Negron M, Scott J, et al. Prophylactic ephedrine and combined spinal epidural. Obstet Gynecol 2005; 106: 466-72.
12.    Gau-Yang C, Cheng-Deng K, Ming-JieY, Huey-Ming L, Yuh- Show T. Comparison of supine and upright positions on autonomic nervous activity in late pregnancy: the role of aortocaval compression. Anaesthesia1999; 54: 215-9.


 

 

 

 

Videos :

watch?v